The DOI matches its Crossref record, with a small difference in title or year; 98 of the 99 references it cites were found in a registry or an index.
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Open accessAbstract
Over the past decade, myocardial structure, cardiomyocyte function, and intramyocardial signaling were shown to be specifically altered in heart failure with preserved ejection fraction (HFPEF). A new paradigm for HFPEF development is therefore proposed, which identifies a systemic proinflammatory state induced by comorbidities as the cause of myocardial structural and functional alterations. The new paradigm presumes the following sequence of events in HFPEF: 1) a high prevalence of comorbidities such as overweight/obesity, diabetes mellitus, chronic obstructive pulmonary disease, and salt-sensitive hypertension induce a systemic proinflammatory state; 2) a systemic proinflammatory state causes coronary microvascular endothelial inflammation; 3) coronary microvascular endothelial inflammation reduces nitric oxide bioavailability, cyclic guanosine monophosphate content, and protein kinase G (PKG) activity in adjacent cardiomyocytes; 4) low PKG activity favors hypertrophy development and increases resting tension because of hypophosphorylation of titin; and 5) both stiff cardiomyocytes and interstitial fibrosis contribute to high diastolic left ventricular (LV) stiffness and heart failure development. The new HFPEF paradigm shifts emphasis from LV afterload excess to coronary microvascular inflammation. This shift is supported by a favorable Laplace relationship in concentric LV hypertrophy and by all cardiac chambers showing similar remodeling and dysfunction. Myocardial remodeling in HFPEF differs from heart failure with reduced ejection fraction, in which remodeling is driven by loss of cardiomyocytes. The new HFPEF paradigm proposes comorbidities, plasma markers of inflammation, or vascular hyperemic responses to be included in diagnostic algorithms and aims at restoring myocardial PKG activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The lessened secretion of inflammatory adipocytokines might act to alleviate coronary endothelial inflammation with secondary beneficial effects on microvascular rarefaction and myocardial fibrosis, 2 important mechanisms in the pathogenesis of HFpEF.46–48”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Obesity and diabetes create a pro-inflammatory state and promote endothelial and coronary microvascular dysfunction. 1,7,8”
The cited source says what the claim attributes to it.
In the citing paper
“Obesity, diabetes, and HF result in pro-inflammatory states, 7,31-34 and each are risk factors for infectious disease complications, an important cause of morbidity and mortality in these patient groups.”
In the citing paper
“Inflammation due to sarcopenic obesity results in reduced NO, cyclic guanosine monophosphate (cGMP), and protein kinase G (PKG) activity in cardiomyocytes, leading to LV hypertrophy and stiffness [120].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [120]
In the citing paper
“Inhibition of systemic metabolic inflammation with glucose-lowering drugs is thought to enhance endothelial and cardiomyocyte function”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [70]
In the citing paper
“Indirectly, through a paracrine endothelial signaling, hyperglycemia causes a mitochondrial hyper-production of superoxide, with impaired activation of endothelial nitric oxide synthase.”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [67]
In the citing paper
“As a result, the impaired bioavailability in nitric oxide impairs its downstream cGMP protein kinase G (PKG) pathway in cardiomyocytes which become hypertrophied and stiffened [65,67].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
Ganau, A., Devereux, R. B., Roman, M. J., SIMONE, G. D., Pickering, T. G., Saba, P. S., Vargiu, P., Simongini, I., & LARAGH, J. H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90617-v · Cited by 1,594
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,345
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
Solomon, S. D., Zile, M. R., Pieske, B. M., Voors, A. A., Shah, A. M., Kraigher‐Krainer, E., Shi, V. C., Bransford, T. L., Takeuchi, M., Gong, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61227-6 · Cited by 1,171
Cited by
Sorted by citations
Items 901–1,000 of 1,005
New Management Strategies in Heart Failure
OWENS, A. T., Brozena, S. C., & Jessup, M. L. (2016) · Circulation Research · doi:10.1161/circresaha.115.306567 · Cited by 38
Takahama, H., & Kitakaze, M. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00215.2017 · Cited by 38
Gamrat, A., Surdacki, M. A., Chyrchel, B., & Surdacki, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072090 · Cited by 40
Yu, L., Dong, X., Zhao, J., Xu, Y., Xu, D., Xue, X., Zhou, Z., Huang, Y., Zhao, Q., Luo, L., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.043 · Cited by 38
Fischer, K., Guensch, D. P., Jung, B., King, I., von Tengg-Kobligk, H., Giannetti, N., Eberle, B., & Friedrich, M. G. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008903 · Cited by 37
Smith, A., Altara, R., Amin, G., Habeichi, N. J., Thomas, D. G., Jun, S., Kaplan, A., Booz, G. W., & Zouein, F. A. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026071 · Cited by 39
Characterization of a robust mouse model of heart failure with preserved ejection fraction
Matsiukevich, D., Kovács, A. D., Li, T., Kokkonen-Simon, K. M., Matkovich, S. J., Oladipupo, S. S., & Ornitz, D. M. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00038.2023 · Cited by 39
Predictive value of Killip classification in MINOCA patients
Armillotta, M., Amicone, S., Bergamaschi, L., Angeli, F., Rinaldi, A., Paolisso, P., Stefanizzi, A., Sansonetti, A., Impellizzeri, A., Bodega, F., et al. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.08.011 · Cited by 37
Inflammation in Heart Failure—Future Perspectives
Arvunescu, A. M., Ionescu, R. F., Creţoiu, S. M., Dumitrescu, S. I., Zaharia, O., & Nanea, I. T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247738 · Cited by 38
Sex-related similarities and differences in responses to heart failure therapies
Chyou, J. Y., Qin, H., Butler, J., Voors, A. A., & Lam, C. S. P. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00996-1 · Cited by 39
Risk of heart failure in inflammatory bowel disease: a Swedish population-based study
Sun, J., Yao, J., Olén, O., Halfvarson, J., Bergman, D., Ebrahimi, F., Rosengren, A., Sundström, J., & Ludvigsson, J. F. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae338 · Cited by 39
Long-Term Cardiovascular Risk and Maternal History of Pre-Eclampsia
Palmiero, P., Caretto, P., Ciccone, M. M., Maiello, M. R., & on behalf of the I.C.I.S.C.U. (Italian Chapter of International Society Cardiovascular Ultrasound) (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093121 · Cited by 38
Early cardiac changes induced by a hypercaloric Western-type diet in “subclinical” obesity
Gonçalves, N., Silva, A. F., Gonçalves‐Rodrigues, P., Correia, E., Moura, C. C., Eloy, C., Roncon‐Albuquerque, R., Falcão‐Pires, I., & Leite-Moreira, A. F. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00684.2015 · Cited by 37
Ladeiras‐Lopes, R., Moreira, H. T., Bettencourt, N., Fontes‐Carvalho, R., Sampaio, F., Ambale‐Venkatesh, B., Wu, C. O., Liu, K., Bertoni, A. G., Ouyang, P., et al. (2018) · Diabetes · doi:10.2337/db17-1496 · Cited by 37
Dixon, I., Landry, N. M., & Rattan, S. G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-6657-4_4 · Cited by 37
Heart failure with preserved ejection fraction: Similarities and differences between women and men
Pepine, C. J., Merz, C. N. B., Hajj, S. C. E., Ferdinand, K. C., Hamilton, M. A., Lindley, K. J., Nelson, M. D., Quesada, O., WENGER, N. K., & Fleg, J. L. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.01.003 · Cited by 38
Harada, T., Sunaga, H., Sorimachi, H., Yoshida, K., Kato, T., Kurosawa, K., Nagasaka, T., Koitabashi, N., Iso, T., Kurabayashi, M., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13071 · Cited by 37
Arterial load and right ventricular-vascular coupling in pulmonary hypertension
Oakland, H. T., Joseph, P., Naeije, R., Elassal, A., Cullinan, M., Heerdt, P. M., & Singh, I. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00204.2021 · Cited by 37
Mitochondrial function, dynamics and quality control in the pathophysiology of HFpEF
del Campo, A., Perez, G., Castro, P., Parra, V., & Verdejo, H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166208 · Cited by 39
Mengozzi, A., Pugliese, N. R., Chiriacò, M., Masi, S., Virdis, A., & Taddei, S. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001109 · Cited by 37
Mark, P. B., Mangion, K., Rankin, A. J., Rutherford, E., Lang, N. N., Petrie, M. C., Stoumpos, S., & Patel, R. K. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac146 · Cited by 40
Nitrate’s Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Trial
Zakeri, R., Levine, J. A., Koepp, G. A., Borlaug, B. A., Chirinos, J. A., LeWinter, M. M., VanBuren, P., Dávila‐Román, V. G., Fuentes, L. D. L., Khazanie, P., et al. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001598 · Cited by 37
Teramoto, K., Nadruz Junior, W., Matsushita, K., Claggett, B., John, J. E., Skali, H., Solomon, S., Cheng, S., & Shah, A. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14833 · Cited by 36
Pericyte loss initiates microvascular dysfunction in the development of diastolic dysfunction
Simmonds, S. J., Grootaert, M. O. J., Cuijpers, I., Carai, P., Geuens, N., Herwig, M., Baatsen, P., Hamdani, N., Luttun, A., Heymans, S. R. B., et al. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead129 · Cited by 38
Lund, L. H., James, S. K., DeVore, A. D., Anstrom, K. J., Fudim, M., Aaronson, K. D., Dahlström, U., Desvigne-Nickens, P. M., Fleg, J. L., Yang, S., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3453 · Cited by 36
Microvascular coronary dysfunction and ischemic heart disease: Where are we in 2014?
Petersen, J. W., & Pepine, C. J. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.013 · Cited by 36
Prevalence of asymptomatic heart failure in formerly pre‐eclamptic women: a cohort study
Breetveld, N. M., Ghossein‐Doha, C., van Kuijk, S. M. J., van Dijk, A. P. J., van der Vlugt, M. J., Heidema, W. M., van Neer, J., van Empel, V. P. M., Rocca, H. B., Scholten, R. R., et al. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.16014 · Cited by 36
Kontogeorgos, S., Thunström, E. Ö., Johansson, M. C., & Fu, M. L. X. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.048 · Cited by 36
Subclinical Inflammation in Heart Failure: A Neutrophil Perspective
Vulesevic, B., Sirois, M. G., Allen, B. G., de Denus, S., & White, M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.018 · Cited by 36
Juillière, Y., Venner, C., Filippetti, L., Popovic, B., Huttin, O., & Selton‐Suty, C. (2018) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2018.04.007 · Cited by 36
Huang, C., Lin, T., Wu, Y., Chiang, F., & Wu, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-50427-2 · Cited by 36
Ekström, M., Hellman, A., Hasselström, J., Hage, C., Kahan, T., Ugander, M., Wallén, H., Persson, H., & Linde, C. M. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12612 · Cited by 36
Murphy, K. A., Harsch, B. A., Healy, C. L., Joshi, S. S., Huang, S., Walker, R. E., Wagner, B. M., Ernste, K. M., Huang, W., Block, R., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab111 · Cited by 36
Parente, E. B., Harjutsalo, V., Forsblom, C. M., Groop, P., & on behalf of The FinnDiane Study Group (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01340-4 · Cited by 36
Coronary microvascular dysfunction: Considerations for diagnosis and treatment
Tjoe, B., Barsky, L. L., Wei, J., Samuels, B. A., Azarbal, B., Merz, C. N. B., & SHUFELT, C. L. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20140 · Cited by 36
Kato, S., Fukui, K., Kodama, S., Azuma, M., Nakayama, N., Iwasawa, T., Kimura, K., Tamura, K., & Utsunomiya, D. (2021) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-021-00807-3 · Cited by 36
The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
Weerts, J., Mourmans, S. G. J., Aizpurua, A. B., Schroen, B. L. M., Knackstedt, C., Eringa, E. C., Houben, A. J. H. M., & van Empel, V. P. M. (2022) · Biomolecules · doi:10.3390/biom12020278 · Cited by 37
Nishino, M., Egami, Y., Kawanami, S., Sugae, H., Ukita, K., Kawamura, A., Nakamura, H., Matsuhiro, Y., Yasumoto, K., Tsuda, M., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026301 · Cited by 36
Shahim, B., Shahim, A., Adamo, M., Chioncel, O., Benson, L., Crespo‐Leiro, M. G., Anker, S. D., Coats, A. J. S., Filippatos, G. S., Lainščak, M., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2908 · Cited by 36
Winters, J., Isaacs, A. J., Zeemering, S., Kawczynski, M. J., Maesen, B. A. E., Maessen, J. G., Bidar, E., Boukens, B. J., Hermans, B. J. M., van Hunnik, A., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031220 · Cited by 36
Serelaxin in clinical development: past, present and future
Unemori, E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13695 · Cited by 36
Effect of bariatric surgery on heart failure
Rodríguez-Flores, M., Salinas, C. A., Piché, M., Auclair, A., & Poirier, P. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1352471 · Cited by 36
Forman, D. E., Santanasto, A. J., Boudreau, R. M., Harris, T. B., Kanaya, A. M., Satterfield, S., Simonsick, E. M., Butler, J., Kizer, J. R., & Newman, A. B. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.003915 · Cited by 36
Perez-Shibayama, C., Gil-Cruz, C., Cadosch, N., Lütge, M., Cheng, H.-W., De Martin, A., Frischmann, K., Joachimbauer, A., Onder, L., Papadopoulou, I., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00432-0 · Cited by 35
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know
Marano, P., Wei, J., & Merz, C. N. B. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01116-z · Cited by 35
Lower limb arterial calcification and its clinical relevance with peripheral arterial disease
Dong, Y., Liu, Y., Cheng, P., Liao, H., Jiang, C., Li, Y., Liu, S., & Xu, X. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1271100 · Cited by 35
Wang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 37
A Comprehensive Review: Unraveling the Role of Inflammation in the Etiology of Heart Failure
Pepine, D., Șerban, A. M., Capraș, R.-D., Cismaru, C. M., & Filip, G. A. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10519-w · Cited by 36
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction
Tannenbaum, S. K., & SAYER, G. T. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000163 · Cited by 35
Fu, M. L. X., Zhou, J., Thunström, E. Ö., Almgren, T., Grote, L., Bollano, E., Schaufelberger, M., Johansson, M. C., Petzold, M., Swedberg, K. B., et al. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.01.011 · Cited by 35
Insights into cardiac involvement in ankylosing spondylitis from cardiovascular magnetic resonance
Biesbroek, P. S., Heslinga, S. C., Konings, T. C., van der Horst-Bruinsma, I. E., Hofman, M. B. M., van de Ven, P. M., Kamp, O., van Halm, V. P., Peters, M. J. L., Smulders, Y. M., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-310667 · Cited by 35
Leite, S., Cerqueira, R. J., Ibarrola, J., Fontoura, D., Fernández‐Celis, A., Zannad, F. M., Falcão‐Pires, I., Paulus, W. J., Leite-Moreira, A. F., Rossignol, P., et al. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.118.005596 · Cited by 35
Self-citationPalazzuoli, A., Ruocco, G. M., Evangelista, I., Vivo, O. D., Nuti, R., & Ghio, S. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.01.002 · Cited by 35
Gaibazzi, N., Picano, E., Suma, S., Garibaldi, S., Porter, T. R., Botti, A., Tuttolomondo, D., Tedeschi, A., & Lorenzoni, V. (2020) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2020.01.007 · Cited by 35
Wang, L., Halliday, G., Huot, J. R., Satoh, T., Baust, J., Fisher, A. J., Cook, T. G., HU, J. L., Avolio, T., Goncharov, D. A., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313883 · Cited by 37
Axson, E. L., Sundaram, V., Bloom, C. I., Bottle, A., Cowie, M., & Quint, J. K. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201911-820oc · Cited by 35
Bayés‐Genís, A., Bisbal, F., Núñez, J. E., Santas, E., Lupón, J., Rossignol, P., & Paulus, W. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041110 · Cited by 35
Self-citationOvchinnikov, A. G., Arefieva, T. I., Potekhina, A. V., Filatova, A. Y., Ageev, F. T., & Boytsov, S. A. (2020) · Acta Naturae · doi:10.32607/actanaturae.10990 · Cited by 36
Ratchford, S. M., Clifton, H. L., Salle, D. T. L., Broxterman, R. M., Lee, J. F., Ryan, J. J., Hopkins, P. N., Wright, J. B., Trinity, J. D., Richardson, R. S., et al. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00468.2020 · Cited by 35
Schauer, A., Adams, V., Augstein, A., Jannasch, A., Draskowski, R., Kirchhoff, V., Goto, K., Mittag, J., Galli, R., Männel, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073570 · Cited by 35
Shahim, A., Hourqueig, M., Donal, E., Oger, E., Venkateshvaran, A., Daubert, J., Savarese, G., Linde, C. M., Lund, L. H., & Hage, C. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13533 · Cited by 38
Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure
Soetkamp, D., Gallet, R., Parker, S. J., Holewinski, R. J., Venkatraman, V., Peck, K. A., Goldhaber, J. I., Marbán, E., & Eyk, J. E. V. (2021) · Circulation Research · doi:10.1161/circresaha.119.316311 · Cited by 37
Pabel, S., Hamdani, N., Singh, J. S., & Sossalla, S. T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.752370 · Cited by 36
Clinical Utility of Exercise Training in Heart Failure with Reduced and Preserved Ejection Fraction
Haq, M. A. U., Goh, C. Y., Levinger, I., Wong, C. Y., & Hare, D. L. (2015) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s21372 · Cited by 35
HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1
Faxén, U. L., Hage, C., Benson, L., Zabarovskaja, S., Andréasson, A., Donal, E., Daubert, J., Linde, C. M., Brismar, K., & Lund, L. H. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.06.008 · Cited by 35
Growing Relevance of Cardiac Rehabilitation for an Older Population With Heart Failure
Schopfer, D. W., & Forman, D. E. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.10.010 · Cited by 39
Intercellular Signalling Cross-Talk: To Kill, To Heal and To Rejuvenate
Plotnikov, E. Y., Silachev, D. N., Popkov, V. A., Zorova, L. D., Pevzner, I. B., Zorov, S. D., Jankauskas, S. S., Babenko, V. A., Sukhikh, G. T., & Zorov, D. B. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.12.002 · Cited by 35
Cardiac Rehab for Functional Improvement
Epstein, E., Rosander, A. M., Pazargadi, A., & Taub, P. R. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00462-2 · Cited by 34
Extracellular Vesicles in Adipose Tissue Communication with the Healthy and Pathological Heart
Michel, L. Y. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097745 · Cited by 36
Mentz, R. J., Brunton, S., & Rangaswami, J. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02023-y · Cited by 38
Cardiac macrophage metabolism in health and disease
Kopecky, B. J., & Lavine, K. J. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.10.011 · Cited by 35
Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think
Zdravkovic, M. D., Popadić, V., Klašnja, S., Klasnja, A., Ivankovic, T., Lasica, R., Lović, D. B., Gostiljac, D., & Vasiljević, Z. (2023) · Medicina · doi:10.3390/medicina59122149 · Cited by 34
Simons, S. O., Heptinstall, A. B., Marjenberg, Z. R., Marshall, J., Müllerová, H., Rogliani, P., Nordon, C., & Hawkins, N. M. (2024) · International Journal of COPD · doi:10.2147/copd.s466280 · Cited by 36
Koller, L., Sulzgruber, P., Scharnagl, H., Delgado, G., Goliasch, G., März, W., Winter, M., Kleber, M. E., & Niessner, A. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0600 · Cited by 34
Tsujimoto, T., & Kajio, H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.109 · Cited by 34
Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives
Gori, M., D’Elia, E., & Senni, M. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.060 · Cited by 34
Treatment of Heart Failure With Preserved Ejection Fraction (HFpEF): the Phenotype-Guided Approach
Silverman, D. N., & Shah, S. J. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0709-4 · Cited by 35
Skyttä, T., TUOHINEN, S. S., Luukkaala, T. H., Virtanen, V., Raatikainen, P. M. J., & Kellokumpu‐Lehtinen, P. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1630751 · Cited by 34
Immunometabolic cross-talk in the inflamed heart
Marelli‐Berg, F. M., & Aksentijević, D. (2019) · Cell Stress · doi:10.15698/cst2019.08.194 · Cited by 36
Butler, J., Greene, S. J., Shah, S. H., Shah, S. J., Anstrom, K. J., Kim, R. J., Kalogeropoulos, A. P., Velazquez, E. J., Hernandez, A. F., Desvigne-Nickens, P. M., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.10.011 · Cited by 34
Riley, H. J., Kelly, R. R., Laer, A. O. V., Neff, L. S., Dasgupta, S., Baicu, C. F., McDonald, L. T., LaRue, A. C., Zile, M. R., & Bradshaw, A. D. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00552.2020 · Cited by 34
Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Substudy
Pérez, A. L., Grodin, J. L., Chaikijurajai, T., Wu, Y., Hernandez, A. F., Butler, J., Metra, M., Felker, G. M., Voors, A. A., McMurray, J. J. V., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.01.006 · Cited by 34
Jürgens, M., Schou, M., Hasbak, P., Kjær, A., Wolsk, E., Zerahn, B., Wiberg, M., Brandt, N., Gæde, P., Rossing, P. R., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020418 · Cited by 34
Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events
Regan, J. A., Truby, L., Tahir, U. A., Katz, D. H., Nguyen, M., Kwee, L. C., Deng, S., WILSON, J. G., Mentz, R. J., Kraus, W. E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24226-1 · Cited by 34
Vascular Mineralocorticoid Receptors
Lother, A., & Hein, L. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07418 · Cited by 34
Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure
Toschi‐Dias, E., Rondon, M. U. P. B., Cogliati, C. B., Paolocci, N., Tobaldini, E., & Montano, N. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00162 · Cited by 34
Ma, M., Wu, K., Sun, T., Huang, X., Zhang, B., Chen, Z., Zhao, Z., Zhao, J., & Zhou, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324890 · Cited by 33
Carluccio, E., Biagioli, P., Zuchi, C., Bardelli, G., Murrone, A., Lauciello, R., D’Addario, S., Mengoni, A., Alunni, G., & Ambrosio, G. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0881-5 · Cited by 33
Masci, P. G., Pavon, A. G., Berchier, G., & Schwitter, J. (2019) · BMC Medical Imaging · doi:10.1186/s12880-018-0301-5 · Cited by 33
Shuai, W., Wen, J., Li, X., Wang, D., LI, Y., & Xiang, J. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.017 · Cited by 34
Sharma, K., Mok, Y., Kwak, L., Agarwal, S. K., Chang, P. P., Deswal, A. M., Shah, A. M., Kitzman, D. W., Wruck, L. M., Loehr, L. R., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014669 · Cited by 33
Ambrosio, G., Leiro, M. G. C., Lund, L. H., Coiro, S., Cardona, A., Filippatos, G. S., Ferrari, R., Piepoli, M. F., Coats, A. J. S., Anker, S. D., et al. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.04.001 · Cited by 33
Endothelial Autophagy in Coronary Microvascular Dysfunction and Cardiovascular Disease
Zhao, F., Satyanarayana, G., Zhang, Z., Zhao, J., Ma, X., & Wang, Y. (2022) · Cells · doi:10.3390/cells11132081 · Cited by 35
Deschaine, B., Verma, S., & Rayatzadeh, H. (2022) · Cardiac failure review · doi:10.15420/cfr.2022.11 · Cited by 34
Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction
Zhang, Z., Li, X., He, J., Wang, S., Wang, J., Liu, J., & Wang, Y. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02862-2 · Cited by 33
Morgen, C. S., Haase, C. L., Oral, T. K., Schnecke, V., Varbo, A., & Borlaug, B. A. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.07.008 · Cited by 32
Hammadah, M., Kalogeropoulos, A. P., Georgiopoulou, V. V., Weber, M. E., Wu, Y., Hazen, S. L., Butler, J., & Tang, W. H. W. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.777 · Cited by 33
Can Myocardial Fibrosis Be Reversed?
Frangogiannis, N. G. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.094 · Cited by 33
A change of heart: oxidative stress in governing muscle function?
Breitkreuz, M., & Hamdani, N. (2015) · Biophysical Reviews · doi:10.1007/s12551-015-0175-5 · Cited by 32
Goliasch, G., Zotter‐Tufaro, C., Aschauer, S., Duca, F., Koell, B., Kammerlander, A. A., Ristl, R., Lang, I. M., Maurer, G., Mascherbauer, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134479 · Cited by 32
Metadata
- Authors
- Paulus, W. J., & Tschöpe, C.
- Affiliations
- Amsterdam Cardiovascular Sciences (NL)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Paulus, Walter J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 62
- Issue
- 4
- Pages
- 263-271
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W164205712
- Cited by
- 3,564
- References
- 99
- Citations by year
- 2026: 351 · 2025: 334 · 2024: 320 · 2023: 298 · 2022: 331 · 2021: 364 · 2020: 348 · 2019: 253 · 2018: 225 · 2017: 228 · 2016: 222 · 2015: 148 · 2014: 117 · 2013: 19
- FWCI
- 28.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, systemic inflammation, comorbidities, nitric oxide bioavailability, protein kinase G, cardiomyocyte hypertrophy, diastolic dysfunction, left ventricular stiffness, interstitial fibrosis, cardiac remodeling, Laplace law, obesity, diabetes mellitus, chronic obstructive pulmonary disease, salt-sensitive hypertension
- MeSH terms
- Animals, Coronary Circulation, Endothelium, Vascular, Heart Failure, Humans, Inflammation, Microcirculation, Myocardium, Stroke Volume, Comorbidity, Ventricular Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
